Medicinal Products and Pharma Funded Homecare [5749446]

The procurement process for Medicinal Products and Pharma Funded Homecare by the Regional Business Services Organisation, Procurement and Logistics Service in Northern Ireland has reached completion. This central purchasing body contract, with a maximum framework value of £1,195,500,000, was awarded as of 12 June 2025. The contract was designed to procure pharmaceutical products, classified under CPV code 33600000, through an open procedure.

The procurement covered regions UKN and UKN0 and involved comprehensive joint participation from several health and social care trusts, including the Belfast Health and Social Care Trust and Northern counterparts. The framework agreement included both 'Medicinal Products - Direct to Trust' and 'Medicinal Products - with Pharma Funded Homecare Services', with the potential extension of product lines and spending variability accommodated within the framework terms. This procurement offers substantial business growth opportunities, especially for pharmaceutical companies seeking to expand their presence in the UK healthcare market.

Companies that are equipped to deliver high-quality pharmaceutical products and can adhere to licensing requirements are well-positioned to compete in this opportunity. The framework allows for the introduction of additional products and service variations over its term, enabling scalable growth for suppliers. With a focus on supporting health and social care trusts in Northern Ireland, this tender creates an advantageous platform for businesses providing home medical treatment services or homedelivery of pharmaceutical products to establish long-term contracts and partnerships within the healthcare sector.